We just received data on a new analyst forecast for $TW. Benjamin Budish from Barclays set a price target of 118.0 for TW.
To track analyst ratings and price targets for $TW, check out Quiver Quantitative's $TW forecast page.
Should you buy $TW?
Some analysts are better than others. To view the past performance of Barclays, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$TW Price Targets
Multiple analysts have issued price targets for $TW recently. We have seen 7 analysts offer price targets for $TW in the last 6 months, with a median target of $138.0.
Here are some recent targets:
- Benjamin Budish from Barclays set a target price of $118.0 on 04/30/2026
- Michael Cyprys from Morgan Stanley set a target price of $138.0 on 04/10/2026
- Bill Katz from TD Cowen set a target price of $129.0 on 04/09/2026
- Chris Allen from Keefe, Bruyette & Woods set a target price of $145.0 on 04/08/2026
- Patrick Moley from Piper Sandler set a target price of $112.0 on 02/06/2026
- Kenneth Worthington from JP Morgan set a target price of $140.0 on 02/06/2026
- Alex Kramm from UBS set a target price of $145.0 on 01/09/2026
$TW Insider Trading Activity
$TW insiders have traded $TW stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $TW stock by insiders over the last 6 months:
- WILLIAM HULT (Chief Executive Officer) has made 0 purchases and 3 sales selling 193,668 shares for an estimated $23,095,774.
- SARA FURBER (Chief Financial Officer) has made 0 purchases and 3 sales selling 69,653 shares for an estimated $8,082,287.
- JUSTIN PETERSON (Chief Technology Officer) has made 0 purchases and 4 sales selling 36,692 shares for an estimated $4,386,455.
- DOUGLAS FRIEDMAN (Chief Legal Officer) has made 0 purchases and 4 sales selling 33,360 shares for an estimated $3,878,796.
- ENRICO BRUNI (MD, Co-Head of Global Markets) sold 17,380 shares for an estimated $2,072,912
- TROY DIXON (MD, Co-Head of Global Markets) sold 2,584 shares for an estimated $324,938
- AMY CLACK (Chief Administrative Officer) has made 0 purchases and 3 sales selling 1,948 shares for an estimated $226,396.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$TW Revenue
$TW had revenues of $617.8M in Q1 2026. This is an increase of 21.21% from the same period in the prior year.
You can track TW financials on Quiver Quantitative's TW stock page.
$TW Hedge Fund Activity
We have seen 269 institutional investors add shares of $TW stock to their portfolio, and 291 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,904,984 shares (+22.5%) to their portfolio in Q4 2025, for an estimated $312,401,979
- VIKING GLOBAL INVESTORS LP added 2,768,659 shares (+inf%) to their portfolio in Q4 2025, for an estimated $297,741,588
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,764,352 shares (-73.0%) from their portfolio in Q4 2025, for an estimated $189,738,414
- FRANKLIN RESOURCES INC removed 1,438,641 shares (-39.9%) from their portfolio in Q4 2025, for an estimated $154,711,453
- AQR CAPITAL MANAGEMENT LLC added 1,375,925 shares (+287.3%) to their portfolio in Q4 2025, for an estimated $147,966,974
- JPMORGAN CHASE & CO removed 1,233,903 shares (-50.4%) from their portfolio in Q4 2025, for an estimated $132,693,928
- VOYA INVESTMENT MANAGEMENT LLC removed 1,232,031 shares (-88.0%) from their portfolio in Q4 2025, for an estimated $132,492,613
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
